Rock Springs Capital Management LP
An institutional investment manager in Baltimore, MD. Its Form 13F for the quarter ended Jun 30, 2026, filed Aug 14, 2026. SEC CIK 1595725.
- Reported value$2.05bn
- Positions104
Holdings: 104 positions
The filing on sec.govAs filed, largest first. Reported value is what the manager stated for each position at the quarter end, in US dollars; it is filing data, not a price. Weight is the position's share of the total reported value. Changes compare with the 13F for the quarter ended 2026-03-31.
| Issuer | Class | CUSIP | Reported value$m | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Revolution Medicines IncRVMD | COM | 76155X100 | 207 | 10.1% | 1,105,210 | Reduced−104,255 | |
| Travere Therapeutics IncTVTX | COM | 89422G107 | 124 | 6.0% | 2,179,069 | Added+701,115 | |
| ELI Lilly & CoLLY | COM | 532457108 | 118 | 5.8% | 98,700 | Unchanged | |
| Madrigal Pharmaceuticals IncMDGL | COM | 558868105 | 94.0 | 4.6% | 174,999 | Added+4,000 | |
| Mirum Pharmaceuticals IncMIRM | COM | 604749101 | 93.4 | 4.6% | 798,145 | Reduced−13,149 | |
| Rhythm Pharmaceuticals IncRYTM | COM | 76243J105 | 76.9 | 3.8% | 692,598 | Added+2,850 | |
| Kymera Therapeutics IncKYMR | COM | 501575104 | 52.0 | 2.5% | 453,156 | Reduced−43,715 | |
| Argenx SEARGX | SPONSORED ADR | 04016X101 | 48.9 | 2.4% | 52,750 | Reduced−45,750 | |
| Ascendis Pharma A/S | ORD SHS | K08588103 | 45.0 | 2.2% | 168,750 | New+168,750 | |
| Xenon Pharmaceuticals IncXENE | COM | 98420N105 | 41.3 | 2.0% | 683,907 | Reduced−79,113 | |
| Scholar Rock HLDG CorpSRRK | COM | 80706P103 | 39.3 | 1.9% | 715,452 | Reduced−24,364 | |
| Insmed IncINSM | COM PAR $.01 | 457669307 | 38.6 | 1.9% | 362,150 | Added+47,850 | |
| Penumbra IncPEN | COM | 70975L107 | 36.5 | 1.8% | 115,750 | Reduced−4,750 | |
| Structure Therapeutics IncGPCR | SPONSORED ADS | 86366E106 | 34.4 | 1.7% | 640,317 | Added+100 | |
| Ultragenyx Pharmaceutical inRARE | COM | 90400D108 | 32.3 | 1.6% | 967,855 | Reduced−250,918 | |
| Irhythm Holdings IncIRTC | COM | 450056106 | 32.1 | 1.6% | 269,650 | Added+7,900 | |
| Intuitive Surgical IncISRG | COM NEW | 46120E602 | 30.4 | 1.5% | 76,460 | Reduced−5,540 | |
| Agilon Health IncAGL | COM NEW | 00857U206 | 28.1 | 1.4% | 262,600 | Added+2,600 | |
| Unitedhealth Group IncUNH | COM | 91324P102 | 26.5 | 1.3% | 63,750 | Added+10,750 | |
| Celldex Therapeutics Inc NewCLDX | COM NEW | 15117B202 | 26.0 | 1.3% | 699,146 | Added+48,876 | |
| Erasca IncERAS | COM | 29479A108 | 25.7 | 1.3% | 1,402,150 | Added+298,681 | |
| Neurocrine Biosciences IncNBIX | COM | 64125C109 | 24.4 | 1.2% | 144,750 | Reduced−5,700 | |
| Enliven Therapeutics IncELVN | COM | 29337E102 | 23.6 | 1.2% | 464,625 | Reduced−361,875 | |
| Tenet Healthcare CorpTHC | COM NEW | 88033G407 | 23.4 | 1.1% | 125,000 | Unchanged | |
| Dexcom IncDXCM | COM | 252131107 | 23.1 | 1.1% | 343,000 | Reduced−12,600 | |
| Aclaris Therapeutics IncACRS | COM | 00461U105 | 22.9 | 1.1% | 4,330,532 | Reduced−142,118 | |
| Minimed Group IncMMED | COM | 60365F109 | 22.7 | 1.1% | 1,520,000 | Added+465,000 | |
| Boston Scientific CorpBSX | COM | 101137107 | 22.6 | 1.1% | 528,500 | Added+13,200 | |
| Pharvaris N V | COM | N69605108 | 22.4 | 1.1% | 648,333 | Added+2,800 | |
| Avalyn Pharmaceuticals IncAVLN | COM SHS | 05348Y105 | 21.8 | 1.1% | 662,918 | New+662,918 | |
| Hemab Therapeutics Holdings IncCOAG | COM SHS | 423494103 | 21.1 | 1.0% | 575,432 | New+575,432 | |
| Dyne Therapeutics IncDYN | COM | 26818M108 | 20.9 | 1.0% | 942,154 | Reduced−30,044 | |
| Alnylam Pharmaceuticals IncALNY | COM | 02043Q107 | 20.1 | 1.0% | 66,750 | Reduced−7,250 | |
| Cogent Biosciences IncCOGT | COM | 19240Q201 | 20.0 | 1.0% | 515,917 | Reduced−108,238 | |
| Agios Pharmaceuticals IncAGIO | COM | 00847X104 | 19.8 | 1.0% | 532,563 | Reduced−266,600 | |
| Newamsterdam Pharma Company | ORDINARY SHARES | N62509109 | 19.7 | 1.0% | 582,744 | Reduced−6,050 | |
| Vera Therapeutics IncVERA | CL A | 92337R101 | 18.3 | 0.9% | 427,584 | Reduced−76,001 | |
| Tarsus Pharmaceuticals IncTARS | COM | 87650L103 | 17.4 | 0.9% | 277,087 | Added+51,908 | |
| Heartflow IncHTFL | COM | 42238D107 | 16.8 | 0.8% | 573,500 | Added+1,000 | |
| MBX Biosciences IncMBX | COM | 55287L101 | 16.5 | 0.8% | 298,218 | Added+10,251 | |
| Cytokinetics IncCYTK | COM NEW | 23282W605 | 16.0 | 0.8% | 187,980 | Added+142,616 | |
| Bicara Therapeutics IncBCAX | COM | 055477103 | 15.9 | 0.8% | 535,286 | Added+46,191 | |
| Parabilis Medicines IncPBLS | COM | 698955101 | 15.8 | 0.8% | 578,028 | New+578,028 | |
| ZAI Lab LtdZLAB | ADR | 98887Q104 | 15.5 | 0.8% | 814,707 | Unchanged | |
| Danaher Corp DelDHR | COM | 235851102 | 14.5 | 0.7% | 76,300 | Added+14,800 | |
| Tango Therapeutics IncTNGX | COM | 87583X109 | 14.3 | 0.7% | 456,551 | Added+69,636 | |
| Evolent Health IncEVH | CL A | 30050B101 | 13.6 | 0.7% | 2,500,000 | Reduced−175,000 | |
| PTC Therapeutics IncPTCT | COM | 69366J200 | 13.2 | 0.6% | 162,298 | Added+500 | |
| Mineralys Therapeutics IncMLYS | COM | 603170101 | 13.1 | 0.6% | 484,951 | Added+45,200 | |
| Zenas Biopharma IncZBIO | COM | 98937L105 | 12.7 | 0.6% | 502,077 | Unchanged | |
| Ardelyx IncARDX | COM | 039697107 | 11.4 | 0.6% | 2,241,769 | Reduced−57,704 | |
| Inspire Med Sys IncINSP | COM | 457730109 | 10.9 | 0.5% | 244,000 | Added+112,200 | |
| Bridgebio Pharma IncBBIO | COM | 10806X102 | 10.8 | 0.5% | 144,750 | Added+16,500 | |
| Alkermes plc | SHS | G01767105 | 10.5 | 0.5% | 199,811 | Added+15,825 | |
| Summit Therapeutics IncSMMT | COM | 86627T108 | 10.4 | 0.5% | 715,000 | Added+5,000 | |
| Azenta IncAZTA | COM | 114340102 | 10.3 | 0.5% | 403,000 | Reduced−166,100 | |
| Indivior Pharmaceuticals IncINDV | COM | 45579U109 | 10.1 | 0.5% | 245,500 | Added+45,500 | |
| Stryker CorporationSYK | COM | 863667101 | 9.1 | 0.4% | 29,000 | Added+14,200 | |
| Amylyx Pharmaceuticals IncAMLX | COM | 03237H101 | 9.0 | 0.4% | 499,764 | Unchanged | |
| Caris Life Sciences IncCAI | COM | 142152107 | 8.7 | 0.4% | 487,500 | Reduced−75,500 | |
| Omada Health IncOMDA | COM | 68170A108 | 8.2 | 0.4% | 373,000 | Reduced−168,000 | |
| Compass Therapeutics IncCMPX | COM | 20454B104 | 7.7 | 0.4% | 3,524,929 | Added+219,621 | |
| Immunome IncIMNM | COM | 45257U108 | 7.4 | 0.4% | 347,666 | Unchanged | |
| Edap TMS S aFOCL | SPONSORED ADR | 268311107 | 7.2 | 0.4% | 1,386,000 | Added+8,000 | |
| Phreesia IncPHR | COM | 71944F106 | 7.2 | 0.4% | 696,900 | Added+96,500 | |
| Omeros CorpOMER | COM | 682143102 | 6.8 | 0.3% | 718,499 | New+718,499 | |
| Definium Therapeutics IncDFTX | COM SHS | 24477V105 | 6.7 | 0.3% | 143,187 | New+143,187 | |
| Corcept Therapeutics IncCORT | COM | 218352102 | 6.3 | 0.3% | 72,000 | Added+21,750 | |
| Janux Therapeutics IncJANX | COM | 47103J105 | 5.6 | 0.3% | 367,009 | Unchanged | |
| Mobia Med IncMOBI | COMMON STOCK | 60705V103 | 5.6 | 0.3% | 418,200 | New+418,200 | |
| Arcus Biosciences IncRCUS | COM | 03969F109 | 5.5 | 0.3% | 180,000 | Unchanged | |
| Thermo Fisher Scientific IncTMO | COM | 883556102 | 5.0 | 0.2% | 10,000 | Unchanged | |
| Trevi Therapeutics IncTRVI | COM | 89532M101 | 4.8 | 0.2% | 260,000 | New+260,000 | |
| Sionna Therapeutics IncSION | COM | 829401108 | 4.4 | 0.2% | 99,429 | Unchanged | |
| CVS Health CorpCVS | COM | 126650100 | 4.1 | 0.2% | 40,000 | Unchanged | |
| Eyepoint IncEYPT | COM NEW | 30233G209 | 3.8 | 0.2% | 268,519 | Added+9,780 | |
| Ocular Therapeutix IncOCUL | COM | 67576A100 | 3.8 | 0.2% | 383,716 | Unchanged | |
| Spyre Therapeutics IncSYRE | COM NEW | 00773J202 | 3.8 | 0.2% | 42,254 | New+42,254 | |
| Talphera IncTLPH | COM NEW | 00444T209 | 3.7 | 0.2% | 3,589,186 | Unchanged | |
| Roivant Sciences Ltd | SHS | G76279101 | 3.6 | 0.2% | 101,000 | Added+4,000 | |
| Vaxcyte IncPCVX | COM | 92243G108 | 3.5 | 0.2% | 60,250 | Unchanged | |
| Neurogene IncNGNE | COM | 64135M105 | 3.4 | 0.2% | 106,750 | Added+2,411 | |
| Century Therapeutics IncIPSC | COM | 15673T100 | 3.2 | 0.2% | 1,304,347 | Unchanged | |
| Alphatec Holdings IncATEC | COM NEW | 02081G201 | 3.1 | 0.2% | 360,000 | Added+10,000 | |
| Novo-Nordisk a SNVO | ADR | 670100205 | 3.0 | 0.1% | 63,500 | Reduced−26,500 | |
| Olema Pharmaceuticals IncOLMA | COM | 68062P106 | 2.9 | 0.1% | 235,178 | Added+64,800 | |
| Nervgen Pharma CorpNGEN | COM | 64082X203 | 2.5 | 0.1% | 1,208,231 | New+1,208,231 | |
| Medtronic plc | SHS | G5960L103 | 2.4 | 0.1% | 30,900 | New+30,900 | |
| Teva Pharmaceutical Inds Ltd | SPONSORED ADS | 881624209 | 2.0 | <0.1% | 59,000 | Added+13,500 | |
| Dianthus Therapeutics IncDNTH | COM | 252828108 | 2.0 | <0.1% | 20,326 | Reduced−6,431 | |
| Sagimet Biosciences IncSGMT | COM SER A | 786700104 | 1.9 | <0.1% | 250,000 | New+250,000 | |
| Capricor Therapeutics IncCAPR | COM NEW | 14070B309 | 1.8 | <0.1% | 74,448 | New+74,448 | |
| Lenz Therapeutics IncLENZ | COM | 52635N103 | 1.5 | <0.1% | 257,460 | Unchanged | |
| Altimmune IncALT | COM NEW | 02155H200 | 1.4 | <0.1% | 471,465 | New+471,465 | |
| Kailera Therapeutics IncKLRA | COMMON STOCK | 482931102 | 1.4 | <0.1% | 65,000 | New+65,000 | |
| Surgery Partners IncSGRY | COM | 86881A100 | 1.4 | <0.1% | 84,000 | Reduced−124,000 | |
| Axsome Therapeutics Inc.AXSM | COM | 05464T104 | 1.3 | <0.1% | 5,500 | New+5,500 | |
| Oruka Therapeutics IncORKA | COM | 687604108 | 1.1 | <0.1% | 12,051 | Added+7,928 | |
| Viking Therapeutics IncVKTX | COM | 92686J106 | 1.0 | <0.1% | 25,500 | Reduced−70,500 | |
| Legend Biotech CorpLEGN | SPONSORED ADS | 52490G102 | 1.0 | <0.1% | 33,500 | Reduced−7,000 | |
| Glaukos CorpGKOS | COM | 377322102 | 0.7 | <0.1% | 4,750 | New+4,750 | |
| Jasper Therapeutics IncJSPR | COM NEW | 471871202 | 0.5 | <0.1% | 1,100,726 | Unchanged | |
| Biocryst Pharmaceuticals IncBCRX | COM | 09058V103 | 0.2 | <0.1% | 22,124 | Added+9,524 | |
| Moonlake ImmunotherapeuticsMLTX | CLASS A ORD | 61559X104 | 0.2 | <0.1% | 10,696 | Reduced−51,004 |
Sold out: 13 positions
Held at the end of the quarter before and not reported this quarter.
| Issuer | Class | CUSIP | Reported value$ | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Acadia Healthcare Company inACHC | COM | 00404A109 | 0.0 | 0.0% | 0 | Sold out−75,500 | |
| Amicus Therapeutic | COM | 03152W109 | 0.0 | 0.0% | 0 | Sold out−21,062 | |
| Apellis Pharmaceuticals Inc | COM | 03753U106 | 0.0 | 0.0% | 0 | Sold out−162,750 | |
| Arcellx Inc | COMMON STOCK | 03940C100 | 0.0 | 0.0% | 0 | Sold out−169,859 | |
| Ascendis Pharma A/S | SPONSORED ADR | 04351P101 | 0.0 | 0.0% | 0 | Sold out−194,000 | |
| Centessa Pharmaceuticals plc | SPONSORED ADS | 152309100 | 0.0 | 0.0% | 0 | Sold out−351,828 | |
| Edwards Lifesciences CorpEW | COM | 28176E108 | 0.0 | 0.0% | 0 | Sold out−28,900 | |
| Gossamer Bio Inc | COM | 38341P102 | 0.0 | 0.0% | 0 | Sold out−1,609,492 | |
| Jazz Pharmaceuticals plc | SHS USD | G50871105 | 0.0 | 0.0% | 0 | Sold out−5,750 | |
| Regeneron PharmaceuticalsREGN | COM | 75886F107 | 0.0 | 0.0% | 0 | Sold out−10,100 | |
| Soleno Therapeutics Inc | COM | 834203309 | 0.0 | 0.0% | 0 | Sold out−257,253 | |
| SPDR Series Trust | STATE STREET SPD | 78464A870 | 0.0 | 0.0% | 0 | Sold out−30,000 | |
| Terns Pharmaceuticals Inc | COM | 880881107 | 0.0 | 0.0% | 0 | Sold out−113,748 |
Source: SEC EDGAR, Form 13F-HR, accession 0001172661-26-003527 (on sec.gov). Last ingested by Listed: Oct 22, 2026, 05:26 ET. Listed shows no prices and gives no investment advice.